Furthermore, the fluorescence intensity of SREBP1 in BC cells was substantially reduced upon CLDN6 modulation (Supplementary Fig. 2F); however, the extent to which this regulation by CLDN6 affected de novo fatty acid synthesis through modulating SREBP1 necessitates further investigation. The gene discussed is CLDN6; the disease is breast cancer.